These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35081872)

  • 1. Long non-coding RNA prostate cancer-associated transcript 6 inhibited gefitinib sensitivity of non-small cell lung cancer by serving as a competing endogenous RNA of miR-326 to up-regulate interferon-alpha receptor 2.
    Zheng Y; Guo Z; Li Y
    Bioengineered; 2022 Feb; 13(2):3785-3796. PubMed ID: 35081872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G; Zhu J; Liu F; Yang Y
    DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
    Chen ZY; Liu HY; Jiang N; Yuan JM
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00324 affects non-small cell lung cancer cell proliferation and invasion through regulation of the miR-139-5p/IGF1R axis.
    Zhang M; Lin B; Liu Y; Huang T; Chen M; Lian D; Deng S; Zhuang C
    Mol Cell Biochem; 2020 Oct; 473(1-2):193-202. PubMed ID: 32734536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
    Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
    EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-133a-3p attenuates resistance of non-small cell lung cancer cells to gefitinib by targeting SPAG5.
    Li Q; Wang Y; He J
    J Clin Lab Anal; 2021 Jul; 35(7):e23853. PubMed ID: 34057242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between long non-coding RNA PCAT-1 expression and gefitinib resistance in non-small-cell lung cancer cells.
    Wang S; Liu C; Lei Q; Wu Z; Miao X; Zhu D; Yang X; Li N; Tang M; Chen Y; Wang W
    Respir Res; 2021 May; 22(1):146. PubMed ID: 33980216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124.
    Gao Y; Fan X; Li W; Ping W; Deng Y; Fu X
    Biochem Biophys Res Commun; 2014 Mar; 446(1):179-86. PubMed ID: 24582749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-145-5p Modulates Gefitinib Resistance by Targeting NRAS and MEST in Non-Small Cell Lung Cancer.
    Yu C; Li B; Wang J; Zhang Z; Li S; Lei S; Wang Q
    Ann Clin Lab Sci; 2021 Sep; 51(5):625-637. PubMed ID: 34686504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of lncRNA PCAT6 suppresses the growth of non-small cell lung cancer cells by inhibiting macrophages M2 polarization via miR-326/KLF1 axis.
    Chen Y; Hong C; Qu J; Chen J; Qin Z
    Bioengineered; 2022 May; 13(5):12834-12846. PubMed ID: 35609331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer.
    Shan KZ; Yang SF; Deng YJ; Yue PY; Du ZQ
    Acta Biochim Pol; 2022 Oct; 69(4):795-804. PubMed ID: 36257058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC.
    Li X; Zhang X; Yang C; Cui S; Shen Q; Xu S
    Cell Cycle; 2018; 17(14):1772-1783. PubMed ID: 30010468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of long non‑coding RNA GACAT1 suppresses proliferation and induces apoptosis of NSCLC cells by sponging microRNA‑422a.
    Zhong Y; Lin H; Li Q; Liu C; Zhong L
    Int J Mol Med; 2021 Feb; 47(2):659-667. PubMed ID: 33416153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma.
    Huang Z; Ma Y; Zhang P; Si J; Xiong Y; Yang Y
    Anticancer Drugs; 2020 Jan; 31(1):44-54. PubMed ID: 31503013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1-induced ferritin heavy chain 1 pseudogene 3 (FTH1P3) accelerates non-small cell lung cancer gefitinib resistance.
    Zheng G; Chen W; Li W; Ding Y; Tu P; Chen W
    Biochem Biophys Res Commun; 2020 Oct; 530(4):624-631. PubMed ID: 32762943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
    Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
    BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1.
    Jin S; He J; Li J; Guo R; Shu Y; Liu P
    Thorac Cancer; 2018 Oct; 9(10):1262-1270. PubMed ID: 30126075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9.
    Wang FF; Wang S; Xue WH; Cheng JL
    Mol Cell Biochem; 2016 Dec; 423(1-2):29-37. PubMed ID: 27770372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
    Yue J; Lv D; Wang C; Li L; Zhao Q; Chen H; Xu L
    Oncogene; 2018 Aug; 37(31):4300-4312. PubMed ID: 29717264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop.
    Bing Z; Han J; Zheng Z; Liang N
    Life Sci; 2021 Dec; 287():120012. PubMed ID: 34619168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.